Skip to main content

New Products

  • Popsicle rolls out Yosicle line

    ENGLEWOOD CLIFFS, N.J. — Popsicle has grown its brand to include a line of treats that contain nonfat yogurt.

    Yosicle pops are available in four varieties and three shapes, including:

    • Yosicle Torpedo! pops feature three flavors in one low-fat, creamy pop: purple berry, watermelon and vanilla;

  • COPD spurs drug development

    Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention. And combined, the two diseases cause more than 100,000 deaths per year. Fortunately, however, there is a wide range of treatments available for both, many of which work for both diseases.

  • FDA approves Mylan generic HIV drug

    PITTSBURGH — A generic antiretroviral drug for treating HIV infection has won approval from the Food and Drug Administration.

    Mylan announced Wednesday the approval of nevirapine tablets in the 200-mg strength. The drug is a generic version of Boehringer Ingelheim's Viramune. Mylan plans to begin shipping the drug immediately.

    Various versions of the drug had sales of $116.6 million during the 12-month period ended in March, according to IMS Health.

     

  • Molson Coors launches new brews, packaging

    DENVER, Colo. — Molson Coors has rolled out new products and packaging innovations.

    In the United States, the company has introduced the caramel apple spiced ale under its Blue Moon brand and will roll out such brews as lemon berry shandy and snowdrift vanilla porter from Jacob Leinenkugel Brewing Co. during the fall and winter. What's more, the company's MillerCoors division is rolling out Batch 19, a pre-Prohibition style lager, nationwide.

  • FDA approves treatment for vaginal fungus infections

    ALLEGAN, Mich. — The Food and Drug Administration has approved a generic treatment made by Perrigo for fungal infections of the vagina, the company said.

    Perrigo announced the approval of butoconazole nitrate 2% vaginal cream, a generic version of KV Pharmaceutical's Gynazole-1, used to treat vulvovaginal candidiasis, an infection caused by Candida fungus. KV voluntarily discontinued selling the drug in January 2009 due to manufacturing problems.

  • Monkey Sea Monkey Doo develops all-natural, hypoallergenic personal care for little ones

    IRVINE, Calif. — Monkey Sea Monkey Doo, a maker of all-natural hypoallergenic skin and hair care products, has announced the release of a new line for babies and children.

    Monkey Sea Monkey Doo’s body care products are hypoallergenic and do not contain gluten, soy, dairy or oats. The formulas are infused with such ingredients as jojoba oil, olive oil and aloe leaf extract.

  • FDA approves Stiefel acne treatment

    NEW YORK — The Food and Drug Administration has approved a new treatment for acne made by a GlaxoSmithKline subsidiary.

    Stiefel announced the approval of Fabior (tazarotene) foam in the 0.1% strength, calling it the only retinoid in a topical foam for treating acne in patients ages 12 years and older.

    "Stiefel is dedicated to meeting th needs of patients and dermatologists, and we believe Fabior foam will be an important treatment option for people with moderate-to-severe acne," Stiefel VP North America dermatology Jean-Christophe May said.

  • Shamrock Farms expands line of milk-based sports nutrition beverages

    PHOENIX — Shamrock Farms on Monday announced the launch of Rockin' Refuel Muscle Builder — a protein beverage made with real milk designed to be low in carbs and high in protein — through GNC locations.

X
This ad will auto-close in 10 seconds